ES2525772A1 - Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad - Google Patents

Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad Download PDF

Info

Publication number
ES2525772A1
ES2525772A1 ES201431468A ES201431468A ES2525772A1 ES 2525772 A1 ES2525772 A1 ES 2525772A1 ES 201431468 A ES201431468 A ES 201431468A ES 201431468 A ES201431468 A ES 201431468A ES 2525772 A1 ES2525772 A1 ES 2525772A1
Authority
ES
Spain
Prior art keywords
mood
anxiety
disorders
perimidinones
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201431468A
Other languages
English (en)
Other versions
ES2525772B2 (es
Inventor
Eduardo Sobarzo Sánchez
Eugenio Uriarte Villares
José Ángel FONTENLA GIL
Brais RODRÍGUEZ FIDALGO
Marta CIMADEVILA FONDEVILA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
Original Assignee
Universidade de Santiago de Compostela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela filed Critical Universidade de Santiago de Compostela
Priority to ES201431468A priority Critical patent/ES2525772B2/es
Publication of ES2525772A1 publication Critical patent/ES2525772A1/es
Application granted granted Critical
Publication of ES2525772B2 publication Critical patent/ES2525772B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad. La presente invención se refiere a compuestos de fórmula I y a composiciones farmacéuticas que comprenden estos alcaloides para su uso en trastornos del estado del ánimo y ansiedad.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
-
imagen12
imagen13
imagen14
imagen15
imagen16

Claims (1)

  1. imagen1
    imagen2
ES201431468A 2014-10-03 2014-10-03 Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad Active ES2525772B2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201431468A ES2525772B2 (es) 2014-10-03 2014-10-03 Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201431468A ES2525772B2 (es) 2014-10-03 2014-10-03 Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad

Publications (2)

Publication Number Publication Date
ES2525772A1 true ES2525772A1 (es) 2014-12-29
ES2525772B2 ES2525772B2 (es) 2015-04-16

Family

ID=52105570

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201431468A Active ES2525772B2 (es) 2014-10-03 2014-10-03 Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad

Country Status (1)

Country Link
ES (1) ES2525772B2 (es)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009034219A1 (en) * 2007-09-13 2009-03-19 Ant - Advanced Network Technologies Oy Method and system for wireless real-time collection of multichannel digital audio
WO2013050637A1 (es) * 2011-10-04 2013-04-11 Universidade De Santiago De Compostela Nanocápsulas de oxoisoaporfinas para el tratamiento de la depresión

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009034219A1 (en) * 2007-09-13 2009-03-19 Ant - Advanced Network Technologies Oy Method and system for wireless real-time collection of multichannel digital audio
WO2013050637A1 (es) * 2011-10-04 2013-04-11 Universidade De Santiago De Compostela Nanocápsulas de oxoisoaporfinas para el tratamiento de la depresión

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
X Bu et al, Bioorganic & Medicinal Chemistry 2005, vol 13, págs 3657-3665. "Synthesis and cytotoxic activity of N-[(alkylamino)alkyl]-carboxamide derivatives of 7-oxo-7-H-benzo[e]perimidine", esquema 4 *

Also Published As

Publication number Publication date
ES2525772B2 (es) 2015-04-16

Similar Documents

Publication Publication Date Title
PH12015502814B1 (en) 4-membered ring carboxamides used as nematicides
ECSP16071151A (es) Inhibidores de dihidropirrolopiridina de ror-gamma
EA201500926A1 (ru) Фумараты как пролекарства и их применение при лечении различных заболеваний
AR094964A1 (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRASTORNOS RELACIONADOS CON LA FOSFOINOSITIDA 3-CINASA d (PI3Kd)
EA201401054A1 (ru) N-циклиламиды в качестве нематоцидов
UY36175A (es) 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas
EA201892430A1 (ru) Синтез индазолов
CL2015002767A1 (es) Compuestos terapéuticos y composiciones
EA201691141A1 (ru) Соединения против ccr6
EA201700042A1 (ru) Соединения имидазопиридазина
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
EA201691160A1 (ru) Антагонисты s1p3
MX2020006434A (es) Nuevos compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
MX369473B (es) Derivado de indolona sustituido por pirrol, método de preparación del mismo, composición que comprende el mismo y uso del mismo.
EA201600122A1 (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
CY1121116T1 (el) Νεα μεθοδος για την συνθεση αγομελατινης
CL2015001881A1 (es) Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición.
EA201990399A1 (ru) Соединения, композиции и их применение
MX2020006436A (es) Compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
UY36347A (es) Compuestos y su uso como inhibidores de bace
MX2015014470A (es) Analogos de combretastatina.
EA201500736A1 (ru) Пиразолилкарбоксамиды i в качестве ингибиторов crac каналов
ES2482290A1 (es) Inhibidores polares simétricos de colina cinasa con actividad antitumoral
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
ES2525772A1 (es) Síntesis y uso de perimidinonas en trastornos del estado del ánimo y ansiedad

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2525772

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20150416